
Sign up to save your podcasts
Or


We review the current status of the Ocular Therapeutics TKI sustained release delivery system for treatment of neovascular AMD with Dr. Andrew Moshfeghi, Associate Professor of Ophthalmology USC Roski Eye Institute.
By Retina Synthesis4.5
88 ratings
We review the current status of the Ocular Therapeutics TKI sustained release delivery system for treatment of neovascular AMD with Dr. Andrew Moshfeghi, Associate Professor of Ophthalmology USC Roski Eye Institute.

43 Listeners

18 Listeners

100 Listeners

111,948 Listeners

56,508 Listeners

5 Listeners

9,532 Listeners

11 Listeners

47,654 Listeners

50 Listeners

11 Listeners

466 Listeners

19 Listeners

0 Listeners